Sunday, June 26, 2022

An Analysis of Encompass Health Corporation (EHC)’s Potential Price Growth

Encompass Health Corporation’s recently made public that its Director O’Connor Kevin J. acquired Company’s shares for reported $66480.0 on May 06. In the deal valued at $66.48 per share,1,000 shares were bought. As a result of this transaction, O’Connor Kevin J. now holds 3,436 shares worth roughly $ 0.19 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, Williams Terrance bought 354 shares, generating $20,040 in total proceeds. Upon buying the shares at $56.61, the Director now owns 5,258 shares.

In the meantime, UBS initiated its Encompass Health Corporation [EHC] rating to a Buy in a research note published on Tuesday, September 24, 2021; the price target was $98. PT values the company’s stock at a premium of 44.92 to its Tuesday closing price. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early August from “an Outperform” to “a Strong buy”. Barclays also remained covering EHC and has increased its forecast on November 23, 2020 with a “an Overweight” recommendation from previously “an Equal weight” rating.

Price Performance Review of EHC

On Tuesday, Encompass Health Corporation [NYSE:EHC] saw its stock fall -4.31% to $53.98. On the same session, the stock had its day’s lowest price of $53.03, but rose to a high of $55.00. Over the last five days, the stock has lost -3.86%. Encompass Health Corporation shares have fallen nearly -17.28% since the year began. Nevertheless, the stocks have fallen -33.87% over the past one year. While a 52-week high of $85.75 was reached on 04/14/22, a 52-week low of $53.56 was recorded on 06/21/22. SMA at 50 days reached $65.03, while 200 days put it at $66.46. A total of 1.8 million shares were traded, compared to the trading of 1.07 million shares in the previous session.

Levels Of Support And Resistance For EHC Stock

The 24-hour chart illustrates a support level at 53.01, which if violated will result in even more drops to 52.03. On the upside, there is a resistance level at 54.98. A further resistance level may holdings at 55.97. The Relative Strength Index (RSI) on the 14-day chart is 28.38, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.85%. Stochastics %K at 17.27% indicates the stock is a buying.

How much short interest is there in Encompass Health Corporation?

A steep rise in short interest was recorded in Encompass Health Corporation stocks on Apr 28, 2022, growing by 40000.0 shares to a total of 2.65 million shares. Yahoo Finance data shows the prior-month short interest on Mar 30, 2022 was 2.61 million shares. There was a rise of 1.51%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.46% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.67.

Encompass Health Corporation [EHC] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 9,246,887 shares, or roughly 9.27% of the outstanding EHC shares. In other words, the investor’s shares have fallen by -23,430 from its previous 13-F filing of 9270317.0. Additionally, Wellington Management Co. LLP decreased -15.88% of its stake after which the total value it holdings stand at $580,224,899, while BlackRock Fund Advisors added 0.81% of its stake to hold $531.14 million in the firm. Over the last quarter, The Baupost Group LLC purchased 2,283,900 shares of Encompass Health Corporation, while JANA Partners LLC bought -64,909 shares. At present, JPMorgan Investment Management, I is holding 2,828,193 shares valued at $185.36 million. SSgA Funds Management, Inc. owned 2,733,254 shares of the company at the time of its most recent 13F filing, worth $179.14 million.

According to FactSet, Encompass Health Corporation’s share price will average $78.58 in the next year, based on opinions of analysts polled by the firm. This is up nearly 41.82 percent from its previous closing price of $56.41. Analysts expect Encompass Health Corporation stock to reach the higher price of $83.00, while the lowest price estimate is $70.00. However, 13 analysts have rated EHC stock as a Buy in their predictions for 2022.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam